Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Mar 2023
UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...
Read Full NewsClinical Forum Weighs in: Biologic Selection in Asthma and COPD
Treatable Traits in Asthma and COPD: Clinical Forum Perspectives
Biologic Access in Asthma and COPD: Clinical Forum Perspectives
The designation follows phase 2 ClearMEMory data in which the oral NMDA receptor antagonist improved objective cognitive performance over placebo at 12 weeks.
A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.
The phase 1 ASCEND trial is testing a single intrathecal dose of the investigational AAV9 gene therapy INS1201 in young boys with Duchenne muscular dystrophy.
Findings from the phase 3 METEOROID trial showed that satralizumab reduced the risk of relapse in patients with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.
1.
Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?
2.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
3.
Improved end-of-life conversations for cancer patients are identified by a new study.
4.
Weight loss trial reports success for breast cancer patients at one year mark
5.
'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury
1.
Future of Oncology: Targeted Therapies & Collaborative Innovation Shaping Cancer Care in the USA
2.
Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored
3.
Biomimetic Nanovesicles for Breast Cancer: Targeting Senescence to Overcome Chemoresistance
4.
Dormant Tumor Cell Biomarkers for Early Oncologic Surveillance
5.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge